首页> 外文OA文献 >CD8 T cell responses against the immunodominant Theileria parva 1 peptide Tp249-59 are composed of two distinct populations specific for 2 overlapping 11-mer and 10-mer epitopes 3 Short title: Overlapping 11- and 10-mer CD8+ T cell epitopes in Tp2. 4
【2h】

CD8 T cell responses against the immunodominant Theileria parva 1 peptide Tp249-59 are composed of two distinct populations specific for 2 overlapping 11-mer and 10-mer epitopes 3 Short title: Overlapping 11- and 10-mer CD8+ T cell epitopes in Tp2. 4

机译:针对免疫占优势的泰勒虫小体1肽Tp249-59的CD8 T细胞应答由对2个重叠的11-mer和10-mer抗原决定簇3特异性的两个不同种群组成。简称:在Tp2中重叠11和10-mer CD8 + T细胞抗原决定簇。 4

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunity against Theileria parva is associated with CD8 T-cell responses\udthat exhibit immunodominance, focusing the response against limited\udnumbers of epitopes. As candidates for inclusion in vaccines, characterization\udof responses against immunodominant epitopes is a key component\udin novel vaccine development. We have previously demonstrated that the\udTp249–59 and Tp1214–224 epitopes dominate CD8 T-cell responses in BoLAA10\udand BoLA-18 MHC I homozygous animals, respectively. In this\udstudy, peptide–MHC I tetramers for these epitopes, and a subdominant\udBoLA-A10-restricted epitope (Tp298–106), were generated to facilitate accurate\udand rapid enumeration of epitope-specific CD8 T cells. During validation\udof these tetramers a substantial proportion of Tp249–59-reactive T\udcells failed to bind the tetramer, suggesting that this population was\udheterogeneous with respect to the recognized epitope. We demonstrate\udthat Tp250–59 represents a distinct epitope and that tetramers produced\udwith Tp50–59 and Tp49–59 show no cross-reactivity. The Tp249–59 and\udTp250–59 epitopes use different serine residues as the N-terminal anchor\udfor binding to the presenting MHC I molecule. Molecular dynamic modelling\udpredicts that the two peptide–MHC I complexes adopt structurally\uddifferent conformations and Tcell receptor b sequence analysis showed\udthat Tp249–59 and Tp250–59 are recognized by non-overlapping T-cell\udreceptor repertoires. Together these data demonstrate that although differing\udby only a single residue, Tp249–59 and Tp250–59 epitopes form distinct\udligands for T-cell receptor recognition. Tetramer analysis of T. parva-specific\udCD8 T-cell lines confirmed the immunodominance of Tp1214–224 in\udBoLA-A18 animals and showed in BoLA-A10 animals that the Tp249–59\udepitope response was generally more dominant than the Tp250–59 response\udand confirmed that the Tp298–106 response was subdominant.
机译:抵抗Theileria parva的免疫力与CD8 T细胞应答/ ud表现出免疫优势有关,从而使应答集中于有限数量的表位。作为候选疫苗,针对免疫优势表位的表征/ udof反应是新型疫苗开发的关键组成部分。先前我们已经证明,\ udTp249–59和Tp1214–224表位分别在BoLAA10 \ ud和BoLA-18 MHC I纯合动物中占主导的CD8 T细胞反应。在这项研究中,生成了针对这些表位的肽-MHC I四聚体,以及一个主要的\ udBoLA-A10限制性表位(Tp298–106),以促进对表位特异性CD8 T细胞的精确\快速计数。在验证这些四聚体的过程中,相当一部分Tp249-59反应性Tud细胞未能结合四聚体,表明该群体相对于公认的表位而言是异质的。我们证明\ tp250–59代表一个独特的表位,并且与Tp50–59和Tp49–59产生的四聚体没有交叉反应。 Tp249–59和\ udTp250–59表位使用不同的丝氨酸残基作为N末端锚点ud,以与提出的MHC I分子结合。分子动力学模型\预测这两种肽-MHC I复合物在结构上\不同构象,并且Tcell受体b序列分析表明\ udp Tp249–59和Tp250–59被非重叠的T细胞\ udreceptor组成部分识别。这些数据共同表明,尽管仅\ udp残基不同,但Tp249–59和Tp250–59表位形成了不同的\ udligands用于T细胞受体识别。 T. parva特异性\ udCD8 T细胞系的四聚体分析证实了Tp1214–224在\ udBoLA-A18动物中具有免疫优势,并在BoLA-A10动物中显示,Tp249–59 \ udepitope反应通常比Tp250– 59回应\ udand证实Tp298-106回应占主导。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号